In: PATENT NEWS
And innovator companies also scour the literature to make sure that the drugs they may end up producing have not been previously described in the patent or academic literature. These weaknesses arise because patent law, especially as it pertains to drugs, has very little black or white and a whole... Continue reading
In: PATENT NEWS
The Supreme Court of Texas held that a client’s communications with a registered patent agent, made to facilitate the agent’s provision of authorized legal services to the client, fall within the Texas attorney-client privilege. In re Silver, Case No. 16-0682 (Tex., Feb. 23, 2018) (Devine, J). Silver brought a …
In: PATENT NEWS
Trends and Updates in Patent Licensing: What Lies Ahead in 2018. Live Webcast Date: Wednesday, June 13, 2018 at 3:00 pm – 5:00 pm (ET). Intellectual Property Law Live Webcast …
In: PATENT NEWS
Further to our ongoing coverage of post-TC Heartland patent litigation, in a recent development from the Northern District of Illinois, the court granted counterclaim defendants’ motion to dismiss for improper venue. In Shure Incorporated v. ClearOne, Inc., 1-17-cv-03078 (ILND March 16, 2018, Order), the …
In: PATENT NEWS
“It’s far past time that we crack down on patent abuse, which is raising costs for our seniors,” said Senator Tom Cotton in a statement released upon introduction of the PACED Act. “This bill will make sure unscrupulous patent holders can’t game the system and block their competitors from entering... Continue reading
In: PATENT NEWS
60 of Hagley’s patent models to tour China Technical.ly Delaware Full coverage
In: PATENT NEWS
The comparison is based on stays in infringement disputes in which a parallel European opposition proceeding is pending. Substantial differences emerge. A following investigation of the legal arguments for handling stays in Germany raises serious concerns about the German practice with regard to …
In: PATENT NEWS
The US Patent and Trademark Office (PTO) issued a memorandum to patent examiners clarifying the written description requirement of 35 USC § 112(a) for claims drawn to antibodies. The memorandum was spurred by the US Court of Appeals for the Federal Circuit 2017 decision in Amgen v. Sanofi …
In: TRADEMARK NEWS
Datametrex’s Joint Venture Graph Blockchain Announces Application of 4 Patents With Patent and Trademark Offices GlobeNewswire (press release) Full coverage
In: TRADEMARK NEWS
Myanmar Upper House approves new trademark law Lexology Full coverage
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION